PreveCeutical Medical ( (TSE:PREV) ) has issued an update.
PreveCeutical Medical Inc. has announced a non-brokered private placement offering of up to 16,666,667 units at $0.03 per unit, aiming to raise up to $500,000. The proceeds are intended for outstanding payables, operating expenses, and general working capital. The offering’s completion is subject to conditions, including CSE confirmation, and all securities will have a statutory hold period. This move could enhance PreveCeutical’s financial position and support its ongoing research and development efforts.
More about PreveCeutical Medical
PreveCeutical is a health sciences company focused on developing innovative preventive and curative therapies using organic and nature identical products. The company aims to lead in preventive health sciences with five research and development programs, including dual gene therapy for diabetes and obesity, the Sol-gel Program, Nature Identical™ peptides for various ailments, nonaddictive analgesic peptides, and a therapeutic product for athletes with concussions.
YTD Price Performance: -25.00%
Average Trading Volume: 113,567
Technical Sentiment Signal: Sell
Current Market Cap: $9.47M
Find detailed analytics on PREV stock on TipRanks’ Stock Analysis page.